부가기능
Technical Development - Painful Multifocal Arthritis: Therapy with Rhenium 186 Hydroxyethylidenediphosphonate (186Re HEDP) after Failed Treatment with Medication -- Initial Results of a Prospective Study - Our initial results show that systemic treatment with rhenium 186 hydroxyethylidenediphosphonate, or HEDP, can reduce disease activity in patients with polyarthritis due to rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus./
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.